ARCHIVES

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

Cancer Control Survey “a Flop,” Advisory committee Members Say

October 11, 1974

Upton Says He’s Still Undecided About Leaving NCI

September 28, 1979

Drug Slows Tumor Growth In Metastatic Kidney Cancer

July 26, 2002

NCI R01 Payline Stays At 12th Percentile for FY07.

February 9, 2007

Guest Editorial: caBIG Has Another Fundamental Problem: It Relies On “Incoherent” Messaging Standard

April 22, 2011

Obama Promises To Double NIH Budget; McCain Offers “Necessary Funding.”

September 12, 2008